1,853
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Altered Prostaglandin E Receptor Subtype 3 Expression in Lacrimal Glands of Patients with Chronic Stevens-Johnson Syndrome

, MBBS, MS, , BSc DMLT & , MBBS, MSORCID Icon
Pages 343-347 | Received 08 Jul 2021, Accepted 15 Nov 2021, Published online: 03 Feb 2022

References

  • Breyer RM, Clapp L, Coleman RA, et al. Prostanoid receptors (version 2020.5) in the IUPHAR/BPS guide to pharmacology database. IUPHAR/BPS Guide Pharmacol CITE. 2020;2020(5). doi:10.2218/gtopdb/F767/2020.5.
  • Doucette LP, Walter MA. Prostaglandins in the eye: function, expression, and roles in glaucoma. Ophthalmic Genet. 2017;38(2):108–116. doi:10.3109/13816810.2016.1164193.
  • Ueta M, Sotozono C, Yokoi N, Inatomi T, Kinoshita S. Prostaglandin E receptor subtype EP3 expression in human conjunctival epithelium and its changes in various ocular surface disorders. PLoS One. 2011;6(9):e25209. doi:10.1371/journal.pone.0025209.
  • Mieno H, Ueta M, Yamada K, et al. Expression of prostaglandin E2receptor 3 in the eyelid epidermis of patients with Stevens-Johnson syndrome/toxic epidermal necrolysis. Br J Ophthalmol. 2020;104(7):1022–1027. doi:10.1136/bjophthalmol-2018-313587.
  • Ueta M, Matsuoka T, Yokoi N, Prostaglandin KS. E2 suppresses polyinosine-polycytidylic acid (polyI:C)-stimulated cytokine production via prostaglandin E2 receptor (EP) 2 and 3 in human conjunctival epithelial cells. Br J Ophthalmol. 2011;95(6):859–863. doi:10.1136/bjo.2010.199679.
  • Mombaerts I, Bilyk JR, Rose GE, et al., Expert Panel of the Orbital Society. Consensus on diagnostic criteria of idiopathic orbital inflammation using a modified Delphi approach. JAMA Ophthalmol. 2017;135(7):769–776. doi:10.1001/jamaophthalmol.2017.1581.
  • Sotozono C, Ang LP, Koizumi N, et al. New grading system for the evaluation of chronic ocular manifestations in patients with Stevens-Johnson syndrome. Ophthalmology. 2007;114(7):1294‐1302. doi:10.1016/j.ophtha.2006.10.029.
  • Singh S, Mishra DK, Shanbhag S, et al. Lacrimal gland involvement in severe dry eyes after Stevens-Johnson syndrome. Ophthalmology. 2021;128(4):621–624. doi:10.1016/j.ophtha.2020.08.016.
  • Singh S, Ali MJ, Mittal V, Brabletz S, Paulsen F. Immunohistological study of palpebral lobe of the lacrimal gland in severe dry eyes secondary to Stevens-Johnson syndrome. Curr Eye Res. 2020;18:1–7.
  • Lekhanont K, Sathianvichitr K, Pisitpayat P, Anothaisintawee T, Soontrapa K, Udomsubpayakul U. Association between the levels of prostaglandin E2 in tears and severity of dry eye. Int J Ophthalmol. 2019;12(7):1127–1133. doi:10.18240/ijo.2019.07.12.
  • Pholpramool C. Secretory effect of prostaglandins on the rabbit lacrimal gland in vivo. Prostaglandins Med. 1979;3(3):185–192. doi:10.1016/0161-4630(79)90102-2.
  • Pholpramool C, Tangkrisanavinont V. Evidence for the requirement of sympathetic activity in the PGE1-induced lacrimal secretion in rabbits. Arch Int Pharmacodyn Ther. 1983;265(1):128–137.
  • Shim J, Park C, Lee HS, et al. Change in prostaglandin expression levels and synthesizing activities in dry eye disease. Ophthalmology. 2012;119(11):2211–2219. doi:10.1016/j.ophtha.2012.05.038.